Keywords: malignant peripheral nerve sheath tumor, neurofibromatosis type 1, plexiform neurofibroma, atypical neurofibromatous neoplasm of unknown biological potential, molecular diagnosis, target therapy 1
Dose Range: 50100 mg daily
Understanding androgen action in adipose tissue
SubQ Dosing Schedule (Research/Community) Week / Phase Weeks 1-2 Dose per Injection (mcg) 100 mcg Frequency 3x daily, at least 4 hours apart Week / Phase Weeks 3-4 Dose per Injection (mcg) 200 mcg Frequency 3x daily, at least 4 hours apart Week / Phase Weeks 5-12 Dose per Injection (mcg) 300 mcg Frequency 3x daily, at least 4 hours apart Educational only
Understanding your genetic profile helps your provider anticipate side effects and personalize your treatment plan, including whether a lower starting dose or different compound might reduce cold sensitivity while maintaining weight loss benefits
Patients with poorly controlled diabetes can experience both improved blood sugar control and meaningful weight reduction through GLP-1 therapy